Gentel® Biosciences, a protein microarray life sciences company, announces a technology partnership with Eprogen® to create products for the discovery of new autoantibody biomarkers using whole proteome microarrays. Whole proteome microarrays are fabricated from individual cell lines or tissue samples such as tumor biopsies using ProteoSep®, a proprietary protein fractionation technique co-developed by Eprogen and […]
Chip-On-Chip and Gene Expression Used to Study How Yamanaka Factors Trigger Pluripotency SHANGHAI–Agilent Technologies Inc. (NYSE:A – News) today announced its collaboration with a team from the Shanghai Institutes for Biological Sciences and Tongi University that has achieved new insight into how adult cells can be induced to act like embryonic stem cells (ESC), with […]
A major breakthrough publication, published last Friday in the February 27 early edition of the Proceedings of the National Academy of Sciences, describes studies that were greatly aided by utilizing Biolog Phenotype MicroArray technology to advance our understanding of an important class of pathogenic bacteria. At the Rocky Mountain Laboratories of the NIH, NIAID division, […]
SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE:A – News) today announced the introduction of its SurePrint G3 Microarrays. These third-generation Agilent microarrays contain up to one million probes on a standard 1in. x 3 in. glass slide. Initial applications are array-based comparative genomic hybridization (aCGH) and copy number variation (CNV), with other applications to follow. Source: […]
FlexGen, a Dutch Life Sciences company, is active in the genetic research market with a proprietary custom microarray synthesis instrument. The financing will allow FlexGen to speed up the development and global commercialization of its FlexArrayer, an instrument that provides researchers with unprecedented freedom in the production of custom microarrays. FlexGen is collaborating with several […]
MADISON, Wis.–The NMD-Chip Consortium, an initiative of the Seventh Framework Programme for Research and Technological Development, recently selected Roche NimbleGen microarrays to accelerate and simplify genetic research of neuromuscular disorders (NMDs). The NMD-Chip Consortium is comprised of 13 European entities from eight countries whose goal is to further our understanding of NMDs and to investigate […]
Aushon BioSystems, Inc, the leading provider of advanced microarray instrumentation and laboratory services, recently announced that Mark Schmeizl has joined the company as Vice President of North American Sales. Mr. Schmeizl will be responsible for developing and leading the North American sales team, including oversight of sales operations, processes and training. Mr. Schmeizl brings to […]
BOZEMAN, Mont.–Golden Helix announced today the public availability of new technologies that enable faster, more complex genomic SNP and copy number variation (CNV) research and pave the way for association studies on next-generation sequence and microarray data. Marking significant advances in capability and architecture, the company’s SNP & Variation Suite version 7 (SVS 7) was […]
SPOKANE, Wash.–Signature Genomic Laboratories’ flagship microarray, the SignatureChip®, covers regions of the human genome that were known and recently published to be associated with susceptibility to schizophrenia. A study led by investigators from Duke University and published Feb. 6 in PloS Genetics examined 1073 individuals with schizophrenia and 1148 unaffected control individuals. Among individuals with […]
Aushon BioSystems, Inc, the leading provider of advanced microarray instrumentation and laboratory services for biomarker analysis, has appointed Joseph Blanchard as the company’s Chief Operating Officer. Mr. Blanchard brings more than 20 years of leadership experience in the global life sciences market to his new role, including senior level positions in corporate development, operations management, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
